Milrinone Infusion
Syringe pump continuous infusion preparation (200 mcg/mL), inodilator titration, renal dose adjustment, and hypotension surveillance protocol.
Syringe Pump Infusion Preparation (Standard Concentration)
| Vial Presentation | 10 mL vial (1 mg/mL of milrinone lactate) |
|---|---|
| Milrinone Dose | 10 mg (10 mL = one 10 mL vial) |
| Compatible Diluent | 40 mL of D5W or 0.9% Sodium Chloride (NS) |
| Final Syringe Volume | 50 mL |
| Final Concentration | 200 mcg/mL (0.2 mg/mL) |
| Stability | 24 hours at room temperature |
Materials Required
- Milrinone vial 1 mg/mL (10 mL) × 1
- 60 mL Luer-lock syringe
- 0.9% Sodium Chloride (NS) or 5% Dextrose (D5W)
- Sterile drawing-up needle / filter needle
- Dedicated syringe pump infusion label
- Extension line (100 cm)
- Alcohol chlorhexidine swabs
Preparation Procedure (Aseptic Non-Touch Technique)
- Verification: Verify the written physician order, patient identity, body weight, clinical indication, and most recent serum creatinine / creatinine clearance.
- Pre-Infusion Checks: Confirm serum potassium and magnesium are within range, and that intravascular volume is adequate.
- Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
- Vial Check: Check the milrinone vial for:
- Correct drug and strength, milrinone lactate (1 mg/mL)
- Expiry date
- Container integrity, clarity, and absence of precipitate or discoloration
- Withdrawal: Withdraw 10 mL from the vial into a 60 mL Luer-lock syringe (Total milrinone drawn: 10 mL = 10 mg milrinone).
- Dilution: Add 40 mL of 0.9% Sodium Chloride or D5W to a final volume of 50 mL.
- Mixing: Gently invert the syringe several times to ensure uniform mixing.
- Visual Inspection: Inspect solution to ensure it is clear, colorless to pale yellow, and free of visible particles.
- Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
- Syringe Pump Setup: Prime the extension set and install into the syringe pump.
🔒 Lumen Policy: Milrinone forms an immediate precipitate with furosemide (and bumetanide) in the same line. It is also incompatible with imipenem and procainamide. Infuse via a dedicated lumen, and never give loop diuretics through the milrinone line.
⚠️ Line Access: Milrinone is not a vesicant and may be infused via a peripheral or central line, with routine site checks.
Mechanism & Hemodynamic Profile
Milrinone inhibits phosphodiesterase-3, raising intracellular cAMP in myocardium and vascular smooth muscle. Because it acts downstream of the β-receptor, it remains effective in patients on β-blockers or with β-receptor down-regulation.
Cardiac Effect
- Positive inotropy and improved diastolic relaxation (lusitropy)
- Less rise in heart rate than dobutamine
Vascular Effect
- Systemic and pulmonary vasodilation reduce afterload
- Useful in right ventricular failure with raised pulmonary pressures
Pharmacokinetic Caution
- Renally cleared; half-life lengthens markedly in kidney impairment
- Hypotension may persist for hours after stopping the infusion
Administration & Titration
Recommended Dosing Parameters
- Administration Route: Administer via syringe pump; dedicated lumen preferred.
- Loading Dose (Optional): 50 mcg/kg over 10 minutes. Often omitted in the ICU because of the risk of hypotension; give only on explicit clinician order.
- Recommended Starting Dose: 0.25 to 0.375 mcg/kg/min (titrate infusion to achieve desired hemodynamic result).
- Typical ICU Titration Range: 0.25 to 0.75 mcg/kg/min.
- Titration Interval: Adjust slowly (every 2 to 4 hours or longer), because steady state takes several hours to reach.
- Maximum Dose: 0.75 mcg/kg/min, reduced according to renal function (see table).
- Hypovolemia: Correct intravascular volume depletion before initiation.
- Syringe Continuity: Do not allow the infusion to run out. A syringe can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
- Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes discoloured, cloudy, or contaminated.
Hemodynamic Monitoring Requirements
- Monitor arterial blood pressure continuously (invasive arterial line preferred), especially during any loading dose.
- Monitor heart rate and continuous ECG for ventricular ectopy, ventricular tachycardia, and atrial fibrillation.
- Track cardiac output indices where available (echocardiography, ScvO2, cardiac output monitoring).
- Monitor serum creatinine and urine output daily; adjust the dose if renal function changes.
- Check serum potassium and magnesium; correct deficits to reduce arrhythmia risk.
- Check platelet count periodically for thrombocytopenia.
Clinical Cautions
- Hypotension: Often requires concurrent noradrenaline to maintain perfusion pressure.
- Outflow Obstruction: Avoid in severe obstructive aortic or pulmonic valve disease and hypertrophic obstructive cardiomyopathy.
- Atrial Flutter / Fibrillation: May increase ventricular response rate; ensure rate control.
- Acute Myocardial Infarction: Not recommended in the acute phase.
Renal Dose Adjustment
Milrinone is excreted mainly unchanged in the urine. Reduce the maximum infusion rate according to creatinine clearance:
| Creatinine Clearance (mL/min/1.73 m²) |
Maximum Infusion Rate (mcg/kg/min) |
|---|---|
| > 50 | 0.75 (no adjustment) |
| 50 | 0.43 |
| 40 | 0.38 |
| 30 | 0.33 |
| 20 | 0.28 |
| 10 | 0.23 |
| 5 | 0.20 |
Renal replacement therapy and rapidly changing kidney function require individualized dosing under intensivist and pharmacist guidance.
Hypotension & Arrhythmia Response Protocol
Milrinone is not a vesicant; its principal acute hazards are hypotension and arrhythmias. Unlike short-acting agents, its effects do not resolve within minutes of stopping.
Expected Response
- Mean arterial pressure within prescribed target
- Improving cardiac output and perfusion markers
- No new ventricular ectopy or arrhythmia
- Adequate urine output
Hypotension or New Arrhythmia:
- Reduce or STOP infusion as directed.
- Notify clinician promptly; a vasopressor or fluid bolus may be needed on clinician order.
- Check potassium, magnesium, and 12-lead ECG for arrhythmias.
- Continue close monitoring for several hours, longer in renal impairment.
- Document event in patient clinical record.
Milrinone Infusion Rate Chart (200 mcg/mL)
Shows equivalent dose in mcg/kg/min for a given pump rate (mL/hr) across patient weights. Check the renal adjustment table before using upper-range rates.
| Rate (mL/hr) |
Weight (Kg) and Dose (mcg/kg/min) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 kg | 45 kg | 50 kg | 55 kg | 60 kg | 65 kg | 70 kg | 75 kg | 80 kg | 85 kg | 90 kg | 95 kg | 100 kg | |
| 1 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 |
| 2 | 0.17 | 0.15 | 0.13 | 0.12 | 0.11 | 0.10 | 0.10 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 |
| 3 | 0.25 | 0.22 | 0.20 | 0.18 | 0.17 | 0.15 | 0.14 | 0.13 | 0.12 | 0.12 | 0.11 | 0.11 | 0.10 |
| 4 | 0.33 | 0.30 | 0.27 | 0.24 | 0.22 | 0.21 | 0.19 | 0.18 | 0.17 | 0.16 | 0.15 | 0.14 | 0.13 |
| 5 | 0.42 | 0.37 | 0.33 | 0.30 | 0.28 | 0.26 | 0.24 | 0.22 | 0.21 | 0.20 | 0.19 | 0.18 | 0.17 |
| 6 | 0.50 | 0.44 | 0.40 | 0.36 | 0.33 | 0.31 | 0.29 | 0.27 | 0.25 | 0.24 | 0.22 | 0.21 | 0.20 |
| 7 | 0.58 | 0.52 | 0.47 | 0.42 | 0.39 | 0.36 | 0.33 | 0.31 | 0.29 | 0.27 | 0.26 | 0.25 | 0.23 |
| 8 | 0.67 | 0.59 | 0.53 | 0.48 | 0.44 | 0.41 | 0.38 | 0.36 | 0.33 | 0.31 | 0.30 | 0.28 | 0.27 |
| 9 | 0.75 | 0.67 | 0.60 | 0.55 | 0.50 | 0.46 | 0.43 | 0.40 | 0.38 | 0.35 | 0.33 | 0.32 | 0.30 |
| 10 | 0.83 | 0.74 | 0.67 | 0.61 | 0.56 | 0.51 | 0.48 | 0.44 | 0.42 | 0.39 | 0.37 | 0.35 | 0.33 |
| 11 | 0.92 | 0.81 | 0.73 | 0.67 | 0.61 | 0.56 | 0.52 | 0.49 | 0.46 | 0.43 | 0.41 | 0.39 | 0.37 |
| 12 | 1.00 | 0.89 | 0.80 | 0.73 | 0.67 | 0.62 | 0.57 | 0.53 | 0.50 | 0.47 | 0.44 | 0.42 | 0.40 |
| 13 | 1.08 | 0.96 | 0.87 | 0.79 | 0.72 | 0.67 | 0.62 | 0.58 | 0.54 | 0.51 | 0.48 | 0.46 | 0.43 |
| 14 | 1.17 | 1.04 | 0.93 | 0.85 | 0.78 | 0.72 | 0.67 | 0.62 | 0.58 | 0.55 | 0.52 | 0.49 | 0.47 |
| 15 | 1.25 | 1.11 | 1.00 | 0.91 | 0.83 | 0.77 | 0.71 | 0.67 | 0.62 | 0.59 | 0.56 | 0.53 | 0.50 |
| 16 | 1.33 | 1.19 | 1.07 | 0.97 | 0.89 | 0.82 | 0.76 | 0.71 | 0.67 | 0.63 | 0.59 | 0.56 | 0.53 |
| 17 | 1.42 | 1.26 | 1.13 | 1.03 | 0.94 | 0.87 | 0.81 | 0.76 | 0.71 | 0.67 | 0.63 | 0.60 | 0.57 |
| 18 | 1.50 | 1.33 | 1.20 | 1.09 | 1.00 | 0.92 | 0.86 | 0.80 | 0.75 | 0.71 | 0.67 | 0.63 | 0.60 |
| 19 | 1.58 | 1.41 | 1.27 | 1.15 | 1.06 | 0.97 | 0.90 | 0.84 | 0.79 | 0.75 | 0.70 | 0.67 | 0.63 |
| 20 | 1.67 | 1.48 | 1.33 | 1.21 | 1.11 | 1.03 | 0.95 | 0.89 | 0.83 | 0.78 | 0.74 | 0.70 | 0.67 |
| 21 | 1.75 | 1.56 | 1.40 | 1.27 | 1.17 | 1.08 | 1.00 | 0.93 | 0.88 | 0.82 | 0.78 | 0.74 | 0.70 |
| 22 | 1.83 | 1.63 | 1.47 | 1.33 | 1.22 | 1.13 | 1.05 | 0.98 | 0.92 | 0.86 | 0.81 | 0.77 | 0.73 |
| 23 | 1.92 | 1.70 | 1.53 | 1.39 | 1.28 | 1.18 | 1.10 | 1.02 | 0.96 | 0.90 | 0.85 | 0.81 | 0.77 |
Infusion Conversion (Solution Concentration 200 mcg/mL)
Standard equations for a 200 mcg/mL solution (10 mg in 50 mL):
Rate (mL/hr) = [ Dose (mcg/kg/min) × Weight (kg) × 60 ] / 200
Shortcut: Rate = Dose × Weight × 0.3
Dose (mcg/kg/min) = [ Rate (mL/hour) × Concentration (200 mcg/mL) ] / [ Weight (kg) × 60 ]
Volume (mL) = 50 mcg/kg × Weight (kg) / 200 = 0.25 mL/kg, given over 10 minutes
'Shortcut' example: 70 kg patient at 0.5 mcg/kg/min → 0.5 × 70 × 0.3 = 10.5 mL/hr. A loading dose for the same patient would be 17.5 mL over 10 minutes (105 mL/hr).